Poxel S.A.

€0.15As of Sun 8 Nov 2026, 12:00 UTC
EPA:POXELHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR (30.74%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.31
PE TTM —
TSR TTM (50.97%)
Mkt cap €8.167M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.149
(2.30%)
(82.77%)
Hold 6|10|7|11|1
4Q25
1Q26
2Q26
3Q26
Earnings per share€
—
—
—
—
17.05%
11.61%
14.99%
5.95%
Revenue€M
0.578
0.574
0.579
0.583
15.47%
10.05%
4.87%
6.70%
Peers (US$9.170M)
Cap (US$)
PE
15.57M
—
10.29M
213.1x
6.509M
—
Capital
TTM
5Y
10Y
Leveragex
0.961
(0.015)
(0.014)
EBIT/Intx
13.01
0.355
0.388
Own earn%
180.97
(57.06)
(58.66)
Sh yield%
33.67
26.20
31.07
Owners
Insiders/Inst%
2.92
86.93
Short interest%
2.42
SBC / revenue%
0.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
7–15
$1 testx
−0.1
Incr. ROIC%
9